Using enhanced number and brightness to measure protein oligomerization dynamics in live cells.


Journal

Nature protocols
ISSN: 1750-2799
Titre abrégé: Nat Protoc
Pays: England
ID NLM: 101284307

Informations de publication

Date de publication:
02 2019
Historique:
pubmed: 25 1 2019
medline: 18 4 2019
entrez: 25 1 2019
Statut: ppublish

Résumé

Protein dimerization and oligomerization are essential to most cellular functions, yet measurement of the size of these oligomers in live cells, especially when their size changes over time and space, remains a challenge. A commonly used approach for studying protein aggregates in cells is number and brightness (N&B), a fluorescence microscopy method that is capable of measuring the apparent average number of molecules and their oligomerization (brightness) in each pixel from a series of fluorescence microscopy images. We have recently expanded this approach in order to allow resampling of the raw data to resolve the statistical weighting of coexisting species within each pixel. This feature makes enhanced N&B (eN&B) optimal for capturing the temporal aspects of protein oligomerization when a distribution of oligomers shifts toward a larger central size over time. In this protocol, we demonstrate the application of eN&B by quantifying receptor clustering dynamics using electron-multiplying charge-coupled device (EMCCD)-based total internal reflection microscopy (TIRF) imaging. TIRF provides a superior signal-to-noise ratio, but we also provide guidelines for implementing eN&B in confocal microscopes. For each time point, eN&B requires the acquisition of 200 frames, and it takes a few seconds up to 2 min to complete a single time point. We provide an eN&B (and standard N&B) MATLAB software package amenable to any standard confocal or TIRF microscope. The software requires a high-RAM computer (64 Gb) to run and includes a photobleaching detrending algorithm, which allows extension of the live imaging for more than an hour.

Identifiants

pubmed: 30675035
doi: 10.1038/s41596-018-0111-9
pii: 10.1038/s41596-018-0111-9
doi:

Substances chimiques

EFNB1 protein, human 0
Ephrin-B1 0
Protein Aggregates 0
Recombinant Fusion Proteins 0
EPHB2 protein, human EC 2.7.10.1
Receptor, EphB2 EC 2.7.10.1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

616-638

Subventions

Organisme : NIH HHS
ID : R01 HD075605
Pays : United States
Organisme : NIH HHS
ID : R01 OD019037
Pays : United States

Auteurs

Francesco Cutrale (F)

Translational Imaging Center, Molecular and Computational Biology, University of Southern California, Los Angeles, CA, USA.

Daniel Rodriguez (D)

Laboratory of Theoretical and Applied Mechanics (LMTA), Department of Mechanical Engineering, Universidade Federal Fluminense, Niterói, Brazil.

Verónica Hortigüela (V)

Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.

Chi-Li Chiu (CL)

Center for Applied Molecular Medicine, University of Southern California, Los Angeles, CA, USA.

Jason Otterstrom (J)

ICFO-The Institute of Photonic Sciences, The Barcelona Institute of Science and Technology, Barcelona, Spain.

Stephen Mieruszynski (S)

The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.

Anna Seriola (A)

Center of Regenerative Medicine in Barcelona (CMRB), Hospital Duran i Reynals, Barcelona, Spain.

Enara Larrañaga (E)

Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.

Angel Raya (A)

Center of Regenerative Medicine in Barcelona (CMRB), Hospital Duran i Reynals, Barcelona, Spain.
Centro de Investigación Biomédica en Red (CIBER), Madrid, Spain.
Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.

Melike Lakadamyali (M)

ICFO-The Institute of Photonic Sciences, The Barcelona Institute of Science and Technology, Barcelona, Spain.
Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Scott E Fraser (SE)

Translational Imaging Center, Molecular and Computational Biology, University of Southern California, Los Angeles, CA, USA. sfraser@provost.USC.edu.

Elena Martinez (E)

Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Centro de Investigación Biomédica en Red (CIBER), Madrid, Spain.
Department of Electronics and Biomedical Engineering, University of Barcelona, Barcelona, Spain.

Samuel Ojosnegros (S)

Translational Imaging Center, Molecular and Computational Biology, University of Southern California, Los Angeles, CA, USA. sojosnegros@ibecbarcelona.eu.
Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain. sojosnegros@ibecbarcelona.eu.
Center of Regenerative Medicine in Barcelona (CMRB), Hospital Duran i Reynals, Barcelona, Spain. sojosnegros@ibecbarcelona.eu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH